Logo image of ALVAP.PA

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

EPA:ALVAP - Euronext Paris - Matif - FR0013419876 - Common Stock - Currency: EUR

4.97  +0.14 (+2.9%)

Fundamental Rating

6

ALVAP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 56 industry peers in the Specialty Retail industry. Both the health and profitability get an excellent rating, making ALVAP a very profitable company, without any liquidiy or solvency issues. ALVAP scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, ALVAP could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ALVAP had positive earnings in the past year.
ALVAP had a negative operating cash flow in the past year.
ALVAP had positive earnings in each of the past 5 years.
In the past 5 years ALVAP reported 4 times negative operating cash flow.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

With an excellent Return On Assets value of 9.80%, ALVAP belongs to the best of the industry, outperforming 94.64% of the companies in the same industry.
ALVAP has a better Return On Equity (16.03%) than 85.71% of its industry peers.
ALVAP's Return On Invested Capital of 12.75% is amongst the best of the industry. ALVAP outperforms 89.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALVAP is above the industry average of 8.99%.
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROIC 12.75%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ALVAP has a Profit Margin of 4.35%. This is amongst the best in the industry. ALVAP outperforms 80.36% of its industry peers.
ALVAP's Profit Margin has improved in the last couple of years.
ALVAP has a better Operating Margin (5.90%) than 78.57% of its industry peers.
In the last couple of years the Operating Margin of ALVAP has grown nicely.
ALVAP's Gross Margin of 23.53% is on the low side compared to the rest of the industry. ALVAP is outperformed by 66.07% of its industry peers.
In the last couple of years the Gross Margin of ALVAP has remained more or less at the same level.
Industry RankSector Rank
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALVAP is creating value.
Compared to 1 year ago, ALVAP has about the same amount of shares outstanding.
ALVAP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALVAP has an improved debt to assets ratio.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 4.71 indicates that ALVAP is not in any danger for bankruptcy at the moment.
ALVAP's Altman-Z score of 4.71 is amongst the best of the industry. ALVAP outperforms 89.29% of its industry peers.
ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.21, ALVAP belongs to the top of the industry, outperforming 83.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.71
ROIC/WACC1.84
WACC6.94%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

ALVAP has a Current Ratio of 3.30. This indicates that ALVAP is financially healthy and has no problem in meeting its short term obligations.
ALVAP has a Current ratio of 3.30. This is amongst the best in the industry. ALVAP outperforms 94.64% of its industry peers.
ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.76, ALVAP belongs to the best of the industry, outperforming 91.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

ALVAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.18%.
Measured over the past years, ALVAP shows a very strong growth in Earnings Per Share. The EPS has been growing by 97.48% on average per year.
ALVAP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.12%.
The Revenue has been growing by 41.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

Based on estimates for the next years, ALVAP will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.87% on average per year.
The Revenue is expected to grow by 3.00% on average over the next years.
EPS Next Y4.94%
EPS Next 2Y8.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.56%
Revenue Next 2Y3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

ALVAP is valuated cheaply with a Price/Earnings ratio of 6.14.
Compared to the rest of the industry, the Price/Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 94.64% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALVAP to the average of the S&P500 Index (26.34), we can say ALVAP is valued rather cheaply.
A Price/Forward Earnings ratio of 5.68 indicates a rather cheap valuation of ALVAP.
Based on the Price/Forward Earnings ratio, ALVAP is valued cheaper than 96.43% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.19. ALVAP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.14
Fwd PE 5.68
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALVAP is valued cheaper than 91.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.3
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ALVAP may justify a higher PE ratio.
PEG (NY)1.24
PEG (5Y)0.06
EPS Next 2Y8.87%
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

ALVAP has a Yearly Dividend Yield of 3.41%. Purely for dividend investing, there may be better candidates out there.
ALVAP's Dividend Yield is rather good when compared to the industry average which is at 4.89. ALVAP pays more dividend than 87.50% of the companies in the same industry.
ALVAP's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.05 0.1

5.3 Sustainability

ALVAP pays out 17.39% of its income as dividend. This is a sustainable payout ratio.
DP17.39%
EPS Next 2Y8.87%
EPS Next 3YN/A
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

KUMULUS VAPE

EPA:ALVAP (6/18/2025, 7:00:00 PM)

4.97

+0.14 (+2.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap15.26M
Analysts86
Price Target8.82 (77.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.39%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.14
Fwd PE 5.68
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 1.14
EV/EBITDA 3.3
EPS(TTM)0.81
EY16.3%
EPS(NY)0.88
Fwd EY17.62%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS19.77
BVpS5.37
TBVpS4.36
PEG (NY)1.24
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROCE 17.84%
ROIC 12.75%
ROICexc 17.69%
ROICexgc 22.5%
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexcg growth 3Y1.55%
ROICexcg growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.71
F-Score3
WACC6.94%
ROIC/WACC1.84
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y4.94%
EPS Next 2Y8.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year1.56%
Revenue Next 2Y3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.16%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year20.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A